VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CLBT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CLBTCellebrite DI Ltd.
$11.16$2.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. CLBT
  4. Financial Ratios

Cellebrite DI Ltd. (CLBT) Financial Ratios

Latest Ratios: P/E Ratio 43.5x · EV/EBITDA 28.6x · ROE 19.1%. (2019–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

CLBT Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Market Cap$2.8B$4.5B$4.6B$1.6B$852M$1.3B$2.0B—
Enterprise Value$2.7B$4.4B$4.4B$1.5B$780M$1.1B$1.8B—
P/E Ratio →43.5358.16——7.3918.23——
P/S Ratio5.189.4711.505.073.155.2610.11—
P/B Ratio5.769.3013.7348.1311.53—30.89—
P/FCF17.2428.9337.9617.4974.1346.3732.67—
P/OCF16.4826.6734.9116.1441.4035.9429.63—

P/E links to full P/E history page with 30-year chart

CLBT EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
EV / Revenue—9.2611.054.532.884.679.45—
EV / EBITDA28.6556.2165.6834.0276.1555.19122.02—
EV / EBIT40.3448.29——6.4513.94161.64—
EV / FCF—28.2836.4815.6367.8441.1430.54—

CLBT Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Gross Margin84.2%84.2%84.4%83.6%81.3%82.7%80.6%79.2%
Operating Margin14.0%14.0%14.2%10.2%0.4%5.6%4.7%-0.9%
Net Profit Margin16.5%16.5%-70.5%-24.9%44.6%29.0%3.0%-1.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
ROE19.1%19.1%-152.9%-150.1%46642.9%—9.4%-3.2%
ROA9.6%9.6%-46.3%-17.3%32.5%20.3%1.8%-0.7%
ROIC18.5%18.5%603.1%—49.7%———
ROCE13.8%13.8%16.9%14.0%0.6%7.7%4.8%-0.8%

CLBT Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Debt / Equity0.050.050.030.410.21———
Debt / EBITDA0.290.290.160.331.50———
Net Debt / Equity—-0.21-0.54-5.13-0.98—-2.02-1.30
Net Debt / EBITDA-1.30-1.30-2.68-4.06-7.06-7.01-8.53-29.91
Debt / FCF—-0.65-1.49-1.86-6.29-5.22-2.13-7.71
Interest Coverage——-0.79—811.47538.948.014.39

Net cash position: cash ($124M) exceeds total debt ($23M)

CLBT Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Current Ratio1.561.561.921.661.421.462.032.64
Quick Ratio1.541.541.891.621.381.432.002.60
Cash Ratio1.181.181.511.190.880.971.492.02
Asset Turnover—0.510.580.610.670.720.530.61
Inventory Turnover9.899.897.005.364.996.547.979.05
Days Sales Outstanding—80.5574.9386.75106.22100.06124.2093.95

CLBT Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Dividend Yield—————7.7%0.5%—
Payout Ratio—————140.1%173.0%—

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Earnings Yield2.3%1.7%——13.5%5.5%——
FCF Yield5.8%3.5%2.6%5.7%1.3%2.2%3.1%—
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%—
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%7.7%0.5%—
Shares Outstanding—$250M$209M$190M$195M$162M$187M$187M

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Volatile quarterly cash conversion and earnings quality

Premium Multiples Priced for Sustained Growth

Based on reported figures, CLBT trades at 44.97x trailing earnings and 29.63x trailing EBITDA, a premium to most listed peers that suggests investors are paying for durable double-digit growth rather than current earnings power.

The gap between trailing P/E of 44.97x and forward P/E of 41.79x implies modest expected earnings expansion, which is less than the implied growth typically required to justify such a multiple. The compression from 29.63x trailing EV/EBITDA to 13.72x forward suggests the forward EBITDA estimate is substantially higher, a discrepancy warranting investigation into the underlying assumptions. Relative to the peer group, where SPSC and OSPN trade near 35x and 12.5x earnings respectively, CLBT's multiple appears to embed a scarcity premium tied to its proprietary forensic moat.

Gross Margin Strength Masked by Reinvestment

As reported in quarterly income statements, CLBT's gross margin has held between 80% and 86% across ten quarters, while operating margin has fluctuated from roughly 6% to 18%, indicating that reinvestment rather than unit economics drives most earnings variability.

The consistency of gross margin suggests pricing power and a software-weighted revenue mix, which is a genuine structural strength. However, the wide swing in operating margin points to substantial discretionary spending in R&D and sales that may be deliberately variable. Investors should monitor whether operating margin can sustain levels above 15% once reinvestment normalizes, since current earnings appear more dependent on expense timing than on scalable operating leverage.

Low Returns Reflect Heavy Equity Base

Based on reported figures, CLBT's ROE of 4.8% and ROIC of 5.0% in 2026Q3 remain well below the peer average, suggesting the equity base has grown faster than the earnings it generates.

The expansion of total assets from roughly $557M to $1.1B, combined with a goodwill step-up, has enlarged the capital base without a proportional rise in returns. This pattern may indicate that acquired goodwill is diluting the return metrics even as organic operations improve. Compared with OSPN's 25.4% ROE and 21.7% ROIC, CLBT's returns appear structurally lower, warranting attention to whether recent acquisitions will eventually earn their cost of capital.

Ample Liquidity With Deferred Revenue Ambiguity

According to reported quarterly balance sheets, CLBT's current ratio has held between 1.53 and 2.11, with cash of $223.1M in 2026Q3, indicating a comfortable short-term liquidity buffer relative to near-term obligations.

The current ratio consistently above 1.5 suggests the company can meet short-term obligations without relying on external financing. However, the reported deferred revenue balance reading zero in 2026Q3 after $327.8M in 2025Q4 is a data gap that prevents confident assessment of forward billings. Under severe stress, liquidity would depend heavily on cash preservation, since inventory dependence is low but receivables timing drives significant quarterly swings.

Quality of Earnings Warrants Closer Scrutiny

Based on reported figures, CLBT's 2026Q3 net margin of 17.9% slightly exceeds its operating margin of 18.0% only marginally, while stock-based compensation of $15.4M may be flattering cash flow relative to economic earnings.

The most commonly misapplied ratio for this business model is the trailing P/E, which can understate the economic cost of stock-based compensation that reached $15.4M in a single quarter. A more appropriate lens may be EV/FCF adjusted for SBC, since reported free cash flow margins swing between roughly 11% and 61% and are heavily influenced by working capital timing. Investors should monitor whether the gap between reported earnings and cash generation narrows as the subscription base matures.

Download Financial Ratios Data

Includes 30+ ratios · 7 years · Updated daily

Consensus & Technical Research Suite
Open CLBT Terminal

CLBT Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CLBT — Frequently Asked Questions

Quick answers to the most common questions about buying CLBT stock.

What is Cellebrite DI Ltd.'s P/E ratio?

Cellebrite DI Ltd.'s current P/E ratio is 43.5x. The historical average is 27.9x. This places it at the 67th percentile of its historical range.

What is Cellebrite DI Ltd.'s EV/EBITDA?

Cellebrite DI Ltd.'s current EV/EBITDA is 28.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 57.4x.

What is Cellebrite DI Ltd.'s ROE?

Cellebrite DI Ltd.'s return on equity (ROE) is 19.1%. The historical average is -55.5%.

Is CLBT stock overvalued?

Based on historical data, Cellebrite DI Ltd. is trading at a P/E of 43.5x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Cellebrite DI Ltd.'s profit margins?

Cellebrite DI Ltd. has 84.2% gross margin and 14.0% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Cellebrite DI Ltd. have?

Cellebrite DI Ltd.'s Debt/EBITDA ratio is 0.3x, indicating low leverage. A ratio below 2x is generally considered financially healthy.